PharmaCold A/S: Financial statements 2022
CVR: 41584475
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PharmaCold A/S (CVR 41584475) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 9,694,864 and a net result of DKK 1,443,809. Equity in the 2022 report amounted to DKK 2,048,756. The solvency ratio was 24.3%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 9,694,864
- Profit/Loss
- DKK 1,443,809
- Equity
- DKK 2,048,756
- Total Assets
- DKK 8,439,575
- Employees
- 12
Official annual report
Keep an eye on PharmaCold A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PharmaCold A/S has published its interim report for the period August 12, 2020 – December 31, 2021.
As of February 10, 2022, Christian Bernt Mejdahl has joined the board of directors of PharmaCold A/S.
As of February 10, 2022, René Schumacher Nordbjerg has joined the board of directors of PharmaCold A/S.
As of February 10, 2022, Jens Anthon Gravesen Aagesen has left the board of directors of PharmaCold A/S.
About PharmaCold A/S
PharmaCold A/S is a Danish company of the type Aktieselskab based in Hedehusene, founded in 2020. The company is registered under the industry Engroshandel med hvidevarer og elektriske husholdningsartikler. The company was previously named PharmaCold ApS. The management consists of Bjarne Nordbjerg. The board consists of Morten Willemoes Dyrner (chair), Bjarne Nordbjerg, Christian Bernt Mejdahl and Jess Dahl Madsen. The company is owned by HOLM & HALBY A/S. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 16,342,822 and a net result of DKK 3,777,430 compared with DKK 1,445,995 the year before. Equity in the 2025 report amounted to DKK 7,000,764.